Literature DB >> 7180419

Late sequelae of iatrogenic damage to chorda tympani nerve.

R Chilla, J Nicklatsch, C Arglebe.   

Abstract

Four and a half years following middle ear surgery involving damage to the chorda tympani nerve we conducted a follow-up study in 10 out of 14 patients in whom we had previously investigated gustatory and submandibular gland function, pre- and immediately postoperatively. Following transection of the chorda tympani nerve (5 patients) the secretory volume of the affected gland has risen again but is still lower than that of the healthy gland. The secretory volume of the latter is increased, possibly by compensatory hypertrophy. The still existing dysgeusia, not noticed by the patients, is occasionally slightly improved. After stretching of the chorda tympani nerve (5 patients) the function of the submandibular gland and taste perception on the involved side of the tongue are now nearly fully restored.

Entities:  

Mesh:

Year:  1982        PMID: 7180419     DOI: 10.3109/00016488209128935

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  The effects of tympanic neurectomy and chorda tympanectomy on experimentally induced parotid duct fistulae in rabbits.

Authors:  R Chilla; F J de Paula Lima; M Droese; C Arglebe
Journal:  Arch Otorhinolaryngol       Date:  1985

2.  The changes in submandibular gland size and function following chorda tympani section.

Authors:  Birgül Uzun; Mahmut Özkiriş; Utku Kubilay
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-01-22       Impact factor: 2.503

Review 3.  Oral sensory nerve damage: Causes and consequences.

Authors:  Derek J Snyder; Linda M Bartoshuk
Journal:  Rev Endocr Metab Disord       Date:  2016-06       Impact factor: 6.514

4.  The effect of chorda tympani section on ipsilateral and contralateral salivary secretion and taste in man.

Authors:  R Grant; S Miller; D Simpson; P J Lamey; I Bone
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.